Dyno Therapeutics logo

Dyno Therapeutics

Dyno Therapeutics is pioneering an artificial intelligence (AI) powered approach to gene therapy. Using machine learning and quantitative high-throughput in vivo experimentation, we are inventing new ways to design gene vectors with a focus on cell-targeting capsid proteins from adeno-associated virus (AAV), the most widely-used vector for gene therapies.

Visit Website

Founded

2018

Employees

Between 50 - 100 employees

Raised

$109,000,000

Headquarters Location

1 Kendall Sq Building 1400e Suite 202, Cambridge, MA 02139

Public

FALSE

Acquired

FALSE

CEO

Eric Kelsic
To discover, search, filter and sort thousands of companies and job listings please sign in.
View all the data

Funding Rounds

$100,000,000

May 2021

$9,000,000

May 2020

Investors in Dyno Therapeutics

GV
You can find more tech companies and startups, with financial and hiring information by creating a free account.
Get Started